Cara Therapeutics
CARA
#10952
Rank
NZ$14.82 M
Marketcap
NZ$9.72
Share price
-2.56%
Change (1 day)
21.35%
Change (1 year)

EPS for Cara Therapeutics (CARA)

EPS in 2024 (TTM): NZ-$34.05

According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$38.39. In 2023 the company made an earnings per share (EPS) of NZ-$47.82 a decrease over its 2022 EPS that were of NZ-$34.88.

EPS history for Cara Therapeutics from 2013 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$34.05-28.8%
2023NZ-$47.8237.11%
2022NZ-$34.88-8.09%
2021NZ-$37.95
2019NZ-$54.6220.87%
2018NZ-$45.197.85%
2017NZ-$41.90-9.05%
2016NZ-$46.07110%
2015NZ-$21.9417.65%
2014NZ-$18.65-3.42%
2013NZ-$19.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21-131.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.30-103.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
NZ-$63.50 65.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ-$91.97 139.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ-$4.08-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA